Telegram Group & Telegram Channel
🌟 Navbatagi lmiy safar 🇫🇮!
Finlandiyaning Abo Akademi Universitetiga Professor Outi-Salo Achen taklifiga binoan bir oy davomida ilmiy safarga boraman. Ilg‘or Texnologiyalar Markazidagi "Inson va hayvonlarning patologik holatlari va kasalliklarining in silico imutatsion modellarini ishlab chiqish" nomli amaliy loyiha rahbari sifatida Abo Akademi olimlari – Dr. Phartiban Marimuthu va Prof. Outi Salo-Ahen bilan yaqin hamkorlik qilib kelmoqdaman. 🧪 Bu hamkorlik natijasida 6ta nufuzli jurnallarda qo‘shma maqolalar chop etildi. 📚
Safarda saraton, Parkinson, Altsgeymer va Xantington kabi nevrologik kasalliklarga qarshi samarali dori vositalarini bashorat qilish uchun dorilarni qayta yo'naltirish (Drug repurposing) texnikasidan foydalanib kompyuterda modellashtirish ishlarib olib boriladi. Avvalgi tadqiqotlarimizdan birida glioblastomaga qarshi FDA tomonidan tasdiqlangan 1379 dori ichidan eng samarali 4 tasini aniqlagan edik. Ushbu dorilarning ta’siri in-vitro tajribalarda ham o‘z tasdig‘ini topgan edi. Bu safar sarcoma va ko‘krak saratoni bo‘yicha tadqiqotlarga e’tibor qaratamiz.



tg-me.com/comp_sim_uz/973
Create:
Last Update:

🌟 Navbatagi lmiy safar 🇫🇮!
Finlandiyaning Abo Akademi Universitetiga Professor Outi-Salo Achen taklifiga binoan bir oy davomida ilmiy safarga boraman. Ilg‘or Texnologiyalar Markazidagi "Inson va hayvonlarning patologik holatlari va kasalliklarining in silico imutatsion modellarini ishlab chiqish" nomli amaliy loyiha rahbari sifatida Abo Akademi olimlari – Dr. Phartiban Marimuthu va Prof. Outi Salo-Ahen bilan yaqin hamkorlik qilib kelmoqdaman. 🧪 Bu hamkorlik natijasida 6ta nufuzli jurnallarda qo‘shma maqolalar chop etildi. 📚
Safarda saraton, Parkinson, Altsgeymer va Xantington kabi nevrologik kasalliklarga qarshi samarali dori vositalarini bashorat qilish uchun dorilarni qayta yo'naltirish (Drug repurposing) texnikasidan foydalanib kompyuterda modellashtirish ishlarib olib boriladi. Avvalgi tadqiqotlarimizdan birida glioblastomaga qarshi FDA tomonidan tasdiqlangan 1379 dori ichidan eng samarali 4 tasini aniqlagan edik. Ushbu dorilarning ta’siri in-vitro tajribalarda ham o‘z tasdig‘ini topgan edi. Bu safar sarcoma va ko‘krak saratoni bo‘yicha tadqiqotlarga e’tibor qaratamiz.

BY Computer_simulations_Uz


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/comp_sim_uz/973

View MORE
Open in Telegram


Computer_simulations_Uz Telegram | DID YOU KNOW?

Date: |

Telegram is riding high, adding tens of million of users this year. Now the bill is coming due.Telegram is one of the few significant social-media challengers to Facebook Inc., FB -1.90% on a trajectory toward one billion users active each month by the end of 2022, up from roughly 550 million today.

Start with a fresh view of investing strategy. The combination of risks and fads this quarter looks to be topping. That means the future is ready to move in.Likely, there will not be a wholesale shift. Company actions will aim to benefit from economic growth, inflationary pressures and a return of market-determined interest rates. In turn, all of that should drive the stock market and investment returns higher.

Computer_simulations_Uz from ru


Telegram Computer_simulations_Uz
FROM USA